MRVI · Healthcare · $2.1B
Pre-market $7.65-0.13%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 5,140만 달러로 전년 동기 대비 9% 늘었지만, 직전 분기 6,600만 달러에서 내려와 매출 흐름 자체는 꺾였어요.”
In the company's words · 2026 2분기 earnings call